menu search

GILD / Gilead (GILD) Exercises Option to License Nurix's Candidate

Gilead (GILD) Exercises Option to License Nurix's Candidate
Gilead (GILD) exercises an option under its collaboration agreement with Nurix to license the latter???s investigational targeted protein degrader molecule NX 0479. Read More
Posted: Mar 21 2023, 16:01
Author Name: Zacks Investment Research
Views: 112278

GILD News  

Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023

By Business Wire
November 3, 2023

Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new viral hepatitis data at the America more_horizontal

Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know

By Zacks Investment Research
October 30, 2023

Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know

Gilead Sciences (GILD) closed at $77.88 in the latest trading session, marking a +1.64% move from the prior day. more_horizontal

Gilead (GILD) Gears Up to Report Q3 Earnings: What's in Store?

By Zacks Investment Research
October 30, 2023

Gilead (GILD) Gears Up to Report Q3 Earnings: What's in Store?

Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports its third-quarter 2023 resul more_horizontal

Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider

By Zacks Investment Research
October 24, 2023

Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider

Gilead Sciences (GILD) concluded the recent trading session at $78.15, signifying a +0.76% move from its prior day's close. more_horizontal

7 Healthcare Stocks to invest in for a Healthy Future

By InvestorPlace
October 20, 2023

7 Healthcare Stocks to invest in for a Healthy Future

One of my favorite sectors will always be the healthcare sector. It is practically a basic need for all human beings and is always in constant develop more_horizontal

GILD or VRTX: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
October 19, 2023

GILD or VRTX: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). Bu more_horizontal

Gilead to pay Assembly Bio an initial $100 million as part of 12-year partnership to develop antiviral drugs

By Market Watch
October 17, 2023

Gilead to pay Assembly Bio an initial $100 million as part of 12-year partnership to develop antiviral drugs

Gilead Sciences Inc. GILD, +2.00% announced Tuesday a 12-year partnership Assembly Biosciences Inc. ASMB, +2.11% to develop antiviral therapies, with more_horizontal

Gilead Sciences Stock Is Cheap, With Broad Pipeline

By Seeking Alpha
October 15, 2023

Gilead Sciences Stock Is Cheap, With Broad Pipeline

Gilead Sciences is a California-based biopharmaceutical company with a $95 billion market cap, known for its treatments in HIV, hepatitis B, hepatitis more_horizontal


Search within

Pages Search Results: